HOME › DRUGS › LANADELUMAB
ACTIVE SUBSTANCE / INN

LANADELUMAB

Brand name(s): Takhzyro
EMA LISTED
AUTHORISED
Angioedemas, Hereditary
ACTIVE SUBSTANCE
Lanadelumab
REGULATORS
EMA
SPONSORS / MAH
Takeda Pharmaceuticals International AG Ireland Branch
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TakhzyroTakeda Pharmaceuticals International AG Ireland BranchAuthorised22/11/2018Angioedemas, Hereditary

FULL INTELLIGENCE ON LANADELUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →